Concepedia

Melanie Dujka

MD

Statistics

Publications

9

Citations

559

H-Index

9

Active since

2006

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Vall d'Hebron Hospital Universitari

Memorial Sloan Kettering Cancer Center

Puma Biotechnology (United States)

USC Norris Comprehensive Cancer Center

Melanie Dujka is an author at The University of Texas MD Anderson Cancer Center specializing in molecular oncology, oncology, and medicine.

Publications per year

2006–2022

9

Publications

9

NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells

Claudia P. Miller, Kechen Ban, Melanie Dujka et al. · Blood · 2007 · 205 citations · Full text

Life Sciences, Oncology, Pharmacology +14

Efficacy and Determinants of Response to HER Kinase Inhibition in <i>HER2</i> -Mutant Metastatic Breast Cancer

Lillian M. Smyth, Sarina A. Piha‐Paul, Helen Won et al. · Cancer Discovery · 2019 · 108 citations · Full text

Medicine, Oncology, Pharmacology +17

DNA damage-induced cellular senescence is sufficient to suppress tumorigenesis: a mouse model

Thang Van Nguyen, Nahum Puebla‐Osorio, Hui Pang et al. · The Journal of Experimental Medicine · 2007 · 73 citations · Full text

Life Sciences, Cell Biology, Genetics +17

Mutations Within the Kinase Domain and Truncations of the Epidermal Growth Factor Receptor Are Rare Events in Bladder Cancer: Implications for Therapy

K. Blehm, Philippe E. Spiess, Jolanta Bondaruk et al. · Clinical Cancer Research · 2006 · 62 citations · Full text

Medicine, Oncology, Pharmacology +17

ATM and p53 are essential in the cell-cycle containment of DNA breaks during V(D)J recombination in vivo

Melanie Dujka, Nahum Puebla‐Osorio, Omid Tavana et al. · Oncogene · 2009 · 31 citations

Life Sciences, Genetics, Molecular Biology +11

1–5 of 9